Table 2. Baseline GA measures for the... | American Society of Hematology

Table 2.

Baseline GA measures for the study cohort (N = 105)

GA category	Score	No.	%	Median (range)
Physical function assessment
K-MBI as ADL measurement				105 (24-05)
Impaired K-MBI	≤100	10	9.5
K-IADL				10 (10-28)
Impaired K-IADL	≥12	31	29.5
SPPB				10 (3-12)
Impaired SPPB	≤8	37	35.2
Standing balance consists of 3 subsequent balance tests	≤3 points
Side-by-side stand <10 s	0 points	0
Semitandem stand <10 s	0 points	3	2.9
Tandem stand <10 s		18	17.2
3.0-9.9 s	1 point	9	50.0
>3.0 s or cannot perform	0 points	9	50.0
Gait speed assessment (4 meters), ≥4.82 s
<4.82 s	4 points	48	45.7
4.82-6.20 s	3 points	27	25.7
6.21-8.70 s	2 points	14	13.3
>8.70 s	1 point	6	5.7
Cannot perform	0 points	10	9.5
Sit-and-stand speed, 5 times (≥11.19 s)
<11.19 s	4 points	46	43.8
11.19-13.69 s	3 points	21	20.0
13.70-16.69 s	2 points	17	16.2
>16.7 s	1 point	9	8.6
<60 s or cannot perform	0 points	12	11.4
Handgrip strength
Dominant hand strength, kg				28 (12-46)
Male				34 (12-46)
Female				21 (13-28)
Impaired handgrip strength, dominant hand (≤4th quartile)		24	22.9
Male		10
Female		14
Nutritional status assessment
MNA				25.5 (10.5-33.0)
Impaired MNA	≤23.5	35	33.3
Social support assessment
OARS				16 (8-24)
Impaired OARS	≥18	34	32.4
Cognition function assessment
MMSE-KC				26 (15-30)
Impaired MMSE-KC	≤23	35	33.3
No cognitive impairment	24-30	70	66.7
Mild cognitive impairment	18-23	31	29.5
Severe cognitive impairment	0-17	4	3.8
KNU-DESC				0 (0-3)
Impaired KNU-DESC	≥2	2	1.9
Psychological function assessment
SGDS-K				2 (0-15)
Impaired SGDS-K, moderate depressive symptom	≥6	19	18.1
No depression	0-5	86	81.9
Moderate depressive symptom	6-9	9	8.6
Major depression	≥10	10	9.5
PHQ-9				5 (0-27)
Impaired PHQ-9, mild depression	≥6	50	47.6
No depression	0-5	55	52.4
Mild depression	6-8	18	17.1
Moderate depression	9-14	19	18.1
Severe depression	≥15	13	12.4
NCCN distress thermometer				3 (0-10)
Impaired NCCN distress thermometer	≥3	64	61.0

GA category	Score	No.	%	Median (range)
Physical function assessment
K-MBI as ADL measurement				105 (24-05)
Impaired K-MBI	≤100	10	9.5
K-IADL				10 (10-28)
Impaired K-IADL	≥12	31	29.5
SPPB				10 (3-12)
Impaired SPPB	≤8	37	35.2
Standing balance consists of 3 subsequent balance tests	≤3 points
Side-by-side stand <10 s	0 points	0
Semitandem stand <10 s	0 points	3	2.9
Tandem stand <10 s		18	17.2
3.0-9.9 s	1 point	9	50.0
>3.0 s or cannot perform	0 points	9	50.0
Gait speed assessment (4 meters), ≥4.82 s
<4.82 s	4 points	48	45.7
4.82-6.20 s	3 points	27	25.7
6.21-8.70 s	2 points	14	13.3
>8.70 s	1 point	6	5.7
Cannot perform	0 points	10	9.5
Sit-and-stand speed, 5 times (≥11.19 s)
<11.19 s	4 points	46	43.8
11.19-13.69 s	3 points	21	20.0
13.70-16.69 s	2 points	17	16.2
>16.7 s	1 point	9	8.6
<60 s or cannot perform	0 points	12	11.4
Handgrip strength
Dominant hand strength, kg				28 (12-46)
Male				34 (12-46)
Female				21 (13-28)
Impaired handgrip strength, dominant hand (≤4th quartile)		24	22.9
Male		10
Female		14
Nutritional status assessment
MNA				25.5 (10.5-33.0)
Impaired MNA	≤23.5	35	33.3
Social support assessment
OARS				16 (8-24)
Impaired OARS	≥18	34	32.4
Cognition function assessment
MMSE-KC				26 (15-30)
Impaired MMSE-KC	≤23	35	33.3
No cognitive impairment	24-30	70	66.7
Mild cognitive impairment	18-23	31	29.5
Severe cognitive impairment	0-17	4	3.8
KNU-DESC				0 (0-3)
Impaired KNU-DESC	≥2	2	1.9
Psychological function assessment
SGDS-K				2 (0-15)
Impaired SGDS-K, moderate depressive symptom	≥6	19	18.1
No depression	0-5	86	81.9
Moderate depressive symptom	6-9	9	8.6
Major depression	≥10	10	9.5
PHQ-9				5 (0-27)
Impaired PHQ-9, mild depression	≥6	50	47.6
No depression	0-5	55	52.4
Mild depression	6-8	18	17.1
Moderate depression	9-14	19	18.1
Severe depression	≥15	13	12.4
NCCN distress thermometer				3 (0-10)
Impaired NCCN distress thermometer	≥3	64	61.0

ADL, activity of daily living.

View Large

This Feature Is Available To Subscribers Only